Jackson, Grant Investment Advisers, Inc.
Position in GILD — Gilead Sciences, Inc.
CIK 1650300
STAMFORD, CT
Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$130,761
-$23,521 QoQ
Shares Held
1,035
-6.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,962
of 2,265 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jackson, Grant Investment Advisers, Inc. holds $16,628,871 across 11 Drug Manufacturers - General names. GILD ranks #8 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
30,346 | $7,636,267 | |
| 2 | JNJ |
Johnson & Johnson
|
13,554 | $3,442,309 | |
| 3 | LLY |
ELI LILLY & Co
|
2,102 | $2,521,202 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,533 | $1,610,490 | |
| 5 | AMGN |
Amgen Inc
|
2,382 | $862,569 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,529 | $203,340 | |
| 7 | PFE |
Pfizer Inc
|
6,680 | $160,854 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
1,035 | $130,761 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $130,761 | 1,035 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $154,282 | 1,107 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $135,873 | 1,107 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $122,766 | 1,106 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $122,511 | 1,105 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $123,703 | 1,104 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $101,884 | 1,103 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $92,391 | 1,102 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $75,471 | 1,100 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $70,613 | 964 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $78,093 | 964 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $72,242 | 964 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $79,459 | 1,031 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $85,542 | 1,031 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $82,759 | 964 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $59,469 | 964 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $59,584 | 964 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $57,309 | 964 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $76,603 | 1,055 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $73,691 | 1,055 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $52,884 | 768 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $48,407 | 749 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $43,345 | 744 | Shares | Sole | 2021-03-03 | |
| 2020-09-30 | $46,634 | 738 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $56,397 | 733 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $54,425 | 728 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||